Skip to main content

Table 2 Growth characteristics per MNV type

From: The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration

  Type 1 Type 2 Type 3 p
MNV area, mm2
 Baseline 3.4 ± 3.26 2.84 ± 2.28 0.34 ± 0.53 0.019*
 Endpoint 3.28 ± 3.46 2.96 ± 1.98 0.35 ± 0.28 0.04*
MNV vessel density, mm2/mm2
 Baseline 0.35 ± 0.21 0.53 ± 0.72 0.35 ± 0.28 0.715
 Endpoint 0.37 ± 0.18 0.61 ± 0.33 0.59 ± 0.2 0.05*
 Growth rate, %/year (n) 7.17 ± 53.03 (21) 28.51 ± 50.27 (10) − 62.923 ± 19.97 (3) 0.01*
 % shrink (n) 42.86% (9) 30% (3) 100% (3) 0.099
 % stable (n) 28.57% (6) 20% (2) 0.525
 % grow (n) 28.57% (6) 50% (5) 0.224
  1. *p ≤ 0.05